This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Testa, R. Articles by l'Abbate, A. Search for Related Content PubMed PubMed Citation Articles by Testa, R. Articles by l'Abbate, A. Social Bookmarking                         What's this?

Improvement of Walking Distance in Patients with Intermittent Claudication by Chronic Local Therapy with Isosorbide Dinitrate Ointment

C.N.R. Clinical Physiology Institute and Istituto di Patologia Medica 1, University of Pisa, Pisa, Italy

Andrea Biagini, M.D.

C.N.R. Clinical Physiology Institute and Istituto di Patologia Medica 1, University of Pisa, Pisa, Italy

Claudio Michelassi, M.D.

C.N.R. Clinical Physiology Institute and Istituto di Patologia Medica 1, University of Pisa, Pisa, Italy

Michele Emdin, M.D.

C.N.R. Clinical Physiology Institute and Istituto di Patologia Medica 1, University of Pisa, Pisa, Italy

Maria Giovanna Mazzei, M.D.

C.N.R. Clinical Physiology Institute and Istituto di Patologia Medica 1, University of Pisa, Pisa, Italy

Clara Carpeggiani, M.D.

C.N.R. Clinical Physiology Institute and Istituto di Patologia Medica 1, University of Pisa, Pisa, Italy

Antonio l'Abbate, M.D.

C.N.R. Clinical Physiology Institute and Istituto di Patologia Medica 1, University of Pisa, Pisa, Italy

Isosorbide dinitrate ointment (100 mg tid) was directly applied to 30 male patients with stable, documented intermittent claudication on the areas where ischemic pain was experienced. The symptom-free distance walked (DWA) and the maximum distance reached (MDR) basally, after one, three, six, and twelve months were evaluated by means of treadmill stress tests (TSTs) (angle 0°-velocity constant/patient). After the basal TST, patients were randomly divided into two groups: placebo group and therapy group (double blind), and a further TST was administered one month later. DWA results were 74±8 m vs 297 ±83 m and MDR results were 163 ±22 m vs 506 ±86 m in the therapy group (basal vs one month TST: p < .01) and 94±24 m vs 96±15 m and 232±53 m vs 183±26 m in the placebo group, respectively (basal vs one month TST: NS). Being confident that a significant placebo effect was absent, the authors opened the trial and treated all patients, repeating further TSTs at three, six, and twelve months. The following results were obtained: DWA was 84±13 m, 316±63 m, 374±55 m, and 452±61 m; and MDR was 197 ±29 m, 431 ±59 m, 514 ±57 m, and 547 ±59 m, respectively, in basal conditions and after three, six, and twelve months of treatment (p < .01 for all the values for both DWA and MDR vs basal values). These results suggest the effectiveness of this treatment, independently from a placebo effect, in improving walking tolerance in patients with intermittent claudication.

Angiology, Vol. 39, No. 1, 1-7 (1988)
DOI: 10.1177/000331978803900101


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?